Literature DB >> 19817882

Noxious inhibition of temporal summation is impaired in chronic tension-type headache.

Stuart Cathcart1, Anthony H Winefield, Kurt Lushington, Paul Rolan.   

Abstract

OBJECTIVE: To examine effects of stress on noxious inhibition and temporal summation (TS) in tension-type headache.
BACKGROUND: Stress is the most commonly reported trigger of a chronic tension-type headache (CTH) episode; however, the mechanisms underlying this are unclear. Stress affects pain processing throughout the central nervous system, including, potentially, mechanisms of TS and diffuse noxious inhibitory controls (DNIC), both of which may be abnormal in CTH sufferers (CTH-S). No studies have examined TS of pressure pain or DNIC of TS in CTH-S to date. Similarly, effects of stress on TS or DNIC of TS have not been reported in healthy subjects or CTH-S to date.
METHODS: The present study measured TS and DNIC of TS in CTH-S and healthy controls (CNT) exposed to an hour-long stressful mental task, and in CTH-S exposed to an hour-long neutral condition. TS was elicited at finger and shoulder via 10 pulses from a pressure algometer, applied before and during stimulation from an occlusion cuff at painful intensity.
RESULTS: Algometer pain ratings increased more in the CTH compared with the CNT group, and were inhibited during occlusion cuff more in the CNT compared with CTH groups. Task effects on TS or DNIC were not significant.
CONCLUSIONS: The results indicate increased TS to pressure pain and impaired DNIC of TS in CTH-S. Stress does not appear to aggravate abnormal TS or DNIC mechanisms in CTH-S.

Entities:  

Mesh:

Year:  2009        PMID: 19817882     DOI: 10.1111/j.1526-4610.2009.01545.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  25 in total

Review 1.  Update on medication-overuse headache.

Authors:  Milena De Felice; Michael H Ossipov; Frank Porreca
Journal:  Curr Pain Headache Rep       Date:  2011-02

Review 2.  Central modulation of pain.

Authors:  Michael H Ossipov; Gregory O Dussor; Frank Porreca
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

3.  Deficient pain modulatory systems in patients with mild traumatic brain and chronic post-traumatic headache: implications for its mechanism.

Authors:  Ruth Defrin; Miri Riabinin; Yelena Feingold; Shaul Schreiber; Chaim G Pick
Journal:  J Neurotrauma       Date:  2015-01-01       Impact factor: 5.269

4.  Race Effects on Conditioned Pain Modulation in Youth.

Authors:  Matthew C Morris; Lynn Walker; Stephen Bruehl; Natalie Hellman; Amanda L Sherman; Uma Rao
Journal:  J Pain       Date:  2015-06-15       Impact factor: 5.820

Review 5.  The role of muscles in tension-type headache.

Authors:  Lars Bendtsen; César Fernández-de-la-Peñas
Journal:  Curr Pain Headache Rep       Date:  2011-12

Review 6.  Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies.

Authors:  Ian D Meng; David Dodick; Michael H Ossipov; Frank Porreca
Journal:  Cephalalgia       Date:  2011-03-28       Impact factor: 6.292

Review 7.  Psychological issues in the evaluation and treatment of tension-type headache.

Authors:  Noah L Rosen
Journal:  Curr Pain Headache Rep       Date:  2012-12

8.  Chronic morphine increases Fos-positive neurons after concurrent cornea and tail stimulation.

Authors:  Ashlee Robbins; David Schmitt; Barbara J Winterson; Ian D Meng
Journal:  Headache       Date:  2011-09-19       Impact factor: 5.887

9.  A Subgroup of Chronic Low Back Pain Patients With Central Sensitization.

Authors:  Kosaku Aoyagi; Jianghua He; Andrea L Nicol; Daniel J Clauw; Patricia M Kluding; Stephen Jernigan; Neena K Sharma
Journal:  Clin J Pain       Date:  2019-11       Impact factor: 3.442

10.  Peripheral interleukin-1ß levels are elevated in chronic tension-type headache patients.

Authors:  Chris Della Vedova; Stuart Cathcart; Alan Dohnalek; Vanessa Lee; Mark R Hutchinson; Maarten A Immink; John Hayball
Journal:  Pain Res Manag       Date:  2013-08-16       Impact factor: 3.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.